Home › Funds › SEB Asset Management AB › GILD
SEB Asset Management AB position in GILD
GILEAD SCIENCES INC · Health Care
SEB Asset Management AB reported holding 920,811 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$137.2M, representing 0.51% of its reported portfolio and ranking #29 among its reported holdings. SEB Asset Management AB has disclosed GILD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR
How SEB Asset Management AB's GILD position evolved
SEB Asset Management AB first disclosed a stake in GILD in Q1 2026 at 1,233,000 shares (US$171.8M). Across 3 filings, SEB Asset Management AB increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 920,811 shares valued at US$137.2M — an increase of 84,551 shares quarter over quarter.. Notable position changes include a 32% trim in Q2 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.23M | $171.84M | New |
| Q2 2026 | 836.26K | $105.65M | Reduce |
| Q3 2026 | 920.81K | $137.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on SEB Asset Management AB
FAQ
How long has SEB Asset Management AB held GILD?
SEB Asset Management AB has disclosed GILD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is SEB Asset Management AB's current position in GILD?
As of Q3 2026, SEB Asset Management AB holds 920.81K shares of GILD (GILEAD SCIENCES INC), valued at $137.25M, representing 0.51% of its reported portfolio and ranking #29.
Has SEB Asset Management AB been buying or selling GILD?
In the latest 13F filing (Q3 2026), SEB Asset Management AB increased its position in GILD.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.